Search results
14 maj 2021 · Prazosin decreases the effects of norepinephrine on brain alpha-1 adrenoreceptors and may be a promising agent for the treatment of PTSD, as some studies found it to be effective and well tolerated. A study examined the role of the noradrenergic system in the pathophysiology of PTSD and conducted a systematic review to evaluate the efficacy and ...
5 maj 2020 · Stress induced changes included increased NA and GABA levels in the amygdaloid complex in our study, attributing noradrenaline a possible inhibitory role on fear acquisition. Acetylcholine also has a role in memory modulation in the brain. We also demonstrated increased choline esterase acitivity.
9 lut 2021 · Prazosin, an antagonist of the α 1 adrenoceptor (AR), has been found effective in reducing the symptoms of Posttraumatic Stress Disorder (PTSD) in six randomized controlled trials (RCTs), 1 – 6 although a seventh RCT of prazosin for PTSD was negative. 7 Prazosin’s use in PTSD was initially focused on recurrent distressing dreams (for simplicity...
31 maj 2020 · Stress induced changes included increased NA and GABA levels in the amygdaloid complex in our study, attributing noradrenaline a possible inhibitory role on fear acquisition. Acetylcholine also has a role in memory modulation in the brain. We also demonstrated increased choline esterase acitivity.
The α-1 adrenoreceptor antagonist prazosin has shown promise in the treatment of post-traumatic stress disorder (PTSD) symptoms, but its mechanisms are not well understood. Here we administered prazosin or placebo prior to threat condi-tioning (day 1) and tested subsequent extinction (day 2) and reextinction (day 3) in healthy human participants.
Results showed prazosin significantly improved overall PTSD scores (SMD = -0.31; 95% confidence intervals [CI]: -0.62, -0.01), nightmares (SMD = -0.75; 95% CI: -1.24, -0.27), and sleep quality (SMD = -0.57; 95% CI: -1.02, -0.13).
1 lis 2017 · The α 1 -adrenergic antagonist prazosin has showed good effect against posttraumatic stress disorder–related nightmares in several randomized controlled trials.
